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Introduction
There are multiple reasons for developing new alternatives 
in the field of bone tissue engineering, including the need for 
better tissue replacement materials based on bioreabsorbable 
polymers that can be used as cell system scaffolds (constructs).
An ideal scaffold must have good biocompatibility to 
ensure cell survival and minimal immune response after 
implantation. In addition the scaffolds should have certain 
general requirements such as: biodegradability, bioactivity, 
good physical and mechanical strengths, low immunogenicity 
, ability to support vascularity and adequate pore size1,2. 
In vivo, these materials must provide mechanical support and 
a suitable biological environment for tissue formation, while 
their degradation must closely accompany tissue growth3,4.
Poly(α-hydroxyacids) are aliphatic, bioreabsorbable 
polyesters that have been widely used in medical products 
such as sutures, bone screws, tissue engineering scaffolds 
and drug delivery systems. The advantages of this class of 
materials include their biocompatibility, biodegradability, 
ease of processing and possibility of modulating their 
mechanical properties5,6.
We have reported the synthesis and development of 
a number of bioreabsorbable polylactide-based polymers 
obtained by ring-opening polymerization of lactide and 
glycolide monomers7-10. Their potential use as biomedical 
devices and their biocompatibility with skin, bone, cartilage 
and neuronal tissue also have been explored11-15.
Among the polymers synthesized by the group, we highlight 
the amorphous copolymer poly(L-co-D,L lactide)-PLDLA 
which has molecular weight range of 105 g/mol and glass 
transition temperature of 55-60 oC8,16. The interest in 
using this polymer as biomedical devices in bone tissue 
engineering resides in the fact that its degradation rate can 
vary from 12 to 30 weeks depending on molecular weight, 
design and thickness of device and also, it does not generate 
crystalline fragments that induce tissue acute inflammatory 
response. Besides, it presents suitable mechanical properties 
and stability during degradation. PLDLA membrane has a 
tensile strength of about 47.5 MPa and Young’s modulus 
of 197 MPa whereas PLDLA plates can reach modulus of 
2.0 GPa17, 18. These different mechanical properties call 
attention to the wide range of PLDLA applications in bone 
tissue, which has mechanical properties that can vary from 
100 kPa (pre calcified bone) to modulus of 20 GPa (rigid 
compact bone)19.
In order to give continuity to the process of characterization 
of PLDLA polymer this work aimed to perform an in vitro and 
in vivo preliminary study of PLDLA scaffolds loaded with 
osteoblast-like cells used as constructs for bone regeneration 
in bilateral calvarial defects created in Wistar rats.
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In bone tissue engineering, cell-scaffold constructs are used to stimulate complete, functional 
tissue replacement that does not occur naturally in critical-size defects. In this report, we describe the 
application potential of poly (L-co-D,L lactic acid)-PLDLA 70/30, synthesized in house as constructs 
loaded with osteoblast-like cells on bone tissue engineering. In vitro biological results show that the 
porogen leached PLDLA scaffolds are cytocompatible with osteoblast cells, able to stimulate significant 
cells growth during the first 14 days of culture, during which the morphology and cell behavior of 
osteoblasts cultured on the scaffolds were monitored by scanning electron microscopy (SEM). In vivo, 
PLDLA constructs were implanted in 5 mm bilateral critical-size defects created in rat-calvariae and 
then evaluated histologically 8 and 12 weeks after implantation. The histological results showed that 
PLDLA constructs supported the growth of new tissue, with a degradation rate close to that of native 
bone formation and decrease of inflammatory response over time of implantation. These data provide 
evidences that the synthesized PLDLA polymer has application potential as construct for bone tissue 
engineering.
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Materials and methods
Preparation of PLDLA scaffolds
PLDLA 70/30 (Mw = 180,000 g/mol, determined by GPC 
technique) was synthesized by ring-opening copolymerization 
of L-lactide and D,L lactide monomers, using tin (II) octoate 
as the catalyst, essentially as described by Motta, Duek 8. 
PLDLA scaffolds were obtained by the porogen-leaching 
method. After complete PLDLA dissolution in chloroform 
(10% w/v), 70% (w/v) sucrose (Synth) was added, with the 
pore size being controlled granulometrically to 250-500 μm. 
The solution was poured into a silicon cylindrical mold 5 mm 
in diameter and kept in this recipient until the complete 
evaporation of solvent. Cylindrical samples ( 5x5mm) 
were then punched out of the molds and placed in a 1% 
poly(vinyl alcohol), PVA, solution to remove the sucrose 
particles. For the experiments, PLDLA scaffolds were cutted 
at dimensions of 5mm in diameter and 3 mm in thickness. 
The PLDLA scaffolds were disinfected in 70% ethanol for 
30 min and exposed to UV light for 30 min on each side.
In vitro experiments Cell culture
Osteoblasts were obtained from explants of calvarial from 
three Wistar rats as previously described 20,21. Briefly, the 
skin, soft connective tissues and periosteum were removed 
and then, calvaria were dissected from 15 day old of three 
Wistar rats. In a laminar flow, the calvaria were cut into 
small pieces and distributed in T25 tissue culture dishes in 
which they were cultured in a 5% CO2 atmosphere at 37 
oC 
until confluence. Osteoblasts were cultured in Dulbecco’s 
modified essential medium (DMEM) supplemented with 
10% (v/v) heat-inactivated fetal bovine serum (FBS), 
gentamicin (50 μg/mL), amphotericin B (5 μg/mL), ascorbic 
acid (50 μg/mL) and 10 mM β-glycerophosphate. The cells 
were then harvested using trypsin/EDTA and seeded onto 
96-well culture plates containing the polymeric scaffolds 
of interest.
Cell viability
The cytotoxicity of the scaffolds was assessed by the MTT 
colorimetric assay in which MTT reagent (3-[4,5-dimetylthiazol-
2-yl]-2,5-diphe-nyltetrazolium bromide) was reduced to a 
purple formazan product by the mitochondria of living cells. 
Cells cultured on tissue-culture polystyrene plates (TCPS) 
were used as a positive control and the negative control 
consisted of cells cultured on tissue-culture polystyrene 
plates containing 1% phenol (TCPS+ phenol 1%). Cells 
(2x105 cells/mL in 200 μL of DMEM supplemented with 
10% FBS) were seeded in wells containing the scaffolds and 
incubated for 2 h and 24 h. The culture medium was removed 
and the wells then washed twice with 0.1 M PBS, pH 7.4, 
at 37 oC followed by the addition of 180 μL of DMEM and 
MTT assay mixture (20 μL/well, containing 5 mg of MTT 
reagent/mL). After incubation for 4 h at 37 oC, the cells were 
lysed by adding 200 μL of dimethylsulphoxide (DMSO). 
Subsequently, 100 μL aliquots of the solution in each well 
were transferred to a new plate and the absorbance then 
measured at 570 nm using a microplate reader. (Elx-800-UV, 
Bio-Tek Instruments)
Cell proliferation
Cell proliferation was examined using a Quant-iTTM 
PicoGreen assay kit (Molecular Probes), according to the 
manufacturer’s instructions. The normal procedure described 
in the kit protocol and the accompanying DNA standards 
(up to 1,000 ng/mL) were used. Cells (1x104 cells/mL in 
200 μL of DMEM supplemented with 10% FBS) were 
seeded in wells containing the scaffolds and incubated for 
1, 7, 14 and 21 days. At the end of each period, the medium 
was aspirated from the wells and the scaffolds were washed 
five times with 200 µL of PBS. Subsequently, 200 µL of 
Tris-EDTA (TE) buffer was added to each sample, frozen 
at -80 oC overnight and then thawed at 37 oC. The seeded 
scaffolds were sonicated for 5 min each and samples then 
aliquoted in duplicate (100 µL) into a 96-well flat bottomed 
plate. PicoGreen reagent (100 µL) was added to the wells 
containing standard or sample and the plate then read at 
excitation/emission wavelengths of 485/538 nm in fluorometer 
(LS-55, PerkinElmer). The resulting fluorescence was 
compared with a standard curve of DNA and the cell number 
was calculated by assuming 7.7 pg of DNA/cell22,23.
Cell morphology
Cell morphology was assessed by scanning electron 
microscopy (SEM) after 24 h, 7 and 14 days of culture. 
The samples were rinsed with phosphate-buffered saline (PBS) 
and fixed for 1 h at room temperature in a solution prepared 
by dissolving 2.5% paraformaldehyde, 2.5% glutaraldehyde, 
0.03% picric acid and 1% tannic acid in PBS, and was 
followed by two rinses in PBS. After immersion in 1% (v/v) 
osmium tetroxide (OsO
4
) solution for 1 h, the samples were 
rinsed twice in deionized water and dehydrated in a graded 
ethanol series (70%, 80%, 95% and 100%) for 15 min each. 
The fixed samples were freeze-dried, sputter-coated with 
gold and examined with a JEOL JXA-840A microscope.
Statistical analysis
The data for cell viability and cell proliferation were 
expressed as the mean ± standard deviation (SD) for n=5 
experiments or determinations. Statistical comparisons were 
done using analysis of variance (ANOVA) followed by the 
Tukey test with (p<0.05) indicating significance. All data 
analyses were done using BioEstat 5.0 statistical software.
In vivo experiments Animals and surgery
Eight Wistar rats (250-300 g) 20 weeks old were 
anesthetized with a combination of ketamine and xylazine (50 
mg/kg and 10 mg/kg, i.p., respectively). The dorsal part of the 
cranium was shaved, aseptically prepared for surgery and a 
sagittal incision of ~30 mm was opened over the scalp. The 
periosteum was removed and a full-thickness bone defect (5 
mm in diameter) was trephined in the center of each parietal 
bone using a trephine bur (Figure 1) adapted to a low-speed 
motor (LB100, Beltec ). The right bone defect was filled 
with pre-seeded scaffolds (1 mm thick) while the other was 
left empty (control). The incision was sutured using nylon 
monofilament 4.0. All procedures involving animals were 
approved by the Committee for Ethics in Animal Use of 
the Universidade do Vale do Paraíba (UNIVAP), São José 
dos Campos, SP, Brazil (protocol no. A01/CEP/2009 and 
A038/CEP/2009).
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Tissue processing
Four animals were euthanized 8 and 12 weeks postoperatively 
by an overdose of halothane after which the soft tissues 
were removed and the calvaria fixed in 4% formaldehyde 
for 24 h followed by decalcification in 4.13% EDTA for 
three weeks. Following complete decalcification, samples 
were dehydrated and embedded in paraffin. Serial sections 
3 mm thick were cut on a microtome (Leica RM2245) 
in a longitudinal direction starting at the center of the 
original surgical defect. The samples were then stained with 
hematoxylin-eosin (H&E) and examined by light microscopy 
using a microscope (Eclipse E800 microscope, Nikon).
RESULTS AND DISCUSSION
Cell compatibility assay
Prior to implantation of the PLDLA scaffolds in vivo, 
an in vitro preliminary study of their cytocompatibility was 
performed by culturing osteoblast-like cells on the scaffolds. 
The viability of cells cultured on PLDLA scaffolds after 2 h 
and 24 h was determined by the colorimetric MTT assay. 
Figure 2 shows the viability (absorbance) of cells cultured in 
TCPS wells (positive control), in wells containing PLDLA 
scaffolds and in TCPS containing a toxic substance (10% 
phenol; negative control). The PLDLA scaffolds did not 
adversely affect cell viability compared to positive control 
since the amount of viable cells adhered to substrate) was 
similar in both groups; in contrast, osteoblasts viability was 
markedly affected on negative control when compared to 
positive control and PLDLA scaffolds (p<0.01).
Only after adhered, cells are able to proliferate, spread, 
migrate and produce new extracellular matrix24. Figure 3 
shows the growth curve of cells cultured on PLDLA scaffolds 
as assessed by DNA quantification using Picogreen reagent. 
The number of cells was calculated assuming a DNA 
concentration of 7.7 pg/cell22,23. As can be seen, scaffolds 
not only led cell adhesion on scaffolds surface as well as 
stimulated a progressive increase in osteoblast proliferation 
along the first 14 days of culture (p<0.05).
No control groups were used in this assay because of 
the lack of an adequate experimental model capable of 
accurately representing the biological microenvironment 
of the three-dimensional scaffold structure24. In addition,it 
is well known that the wells of tissue culture plates, which 
are often used as controls for in vitro assays, are incapable 
of supporting cell proliferation at initial cell concentrations 
>104 cells/mL for long periods of time in bidimensional 
systems25.
In the present study, PLDLA scaffolds obtained by 
the porogen-leaching method were used to assess the 
Figure 1. (A) Bilateral 5 mm critical-size calvarial defects created using a surgical trephine drill. (B) Implant of the PLDLA construct 
into the defect on the right; the left defect was empty and served as the control. (C) Suture. (D) Comparison of native calvarial and 
polymeric scaffolds.
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cytocompatibilty and biocompatibility of scaffolds with 
osteoblast-like cells because of the ease with which these 
scaffolds can be manufactured and the possibility of controlling 
pore size and structure26. Figure 4A shows SEM micrograph 
of the surface of a PLDLA scaffold.
The surface was characterized by homogeneously 
distributed irregular pores, with a range of pore sizes and 
surface topography that provided good interaction between 
cells and PLDLA scaffold surface during the first 24h of 
culture (Figure 4B). Osteoblast-like cells adhered on scaffolds 
and had a flattened, elongated or polygonal morphology with 
cytoplasmic projections extending away from the central 
body to the top of adjacent wall pores.
From day 7 to 14 of culture, several non-specific areas 
of the material surface were covered by a cellular layer as a 
result of osteoblast proliferation and migration (Figure 4 C,D). 
These findings confirmed the cytocompatibility of PLDLA 
scaffolds with osteoblast-like cells and their ability to 
support suitable cell growth that could be useful in bone 
tissue engineering applications.
Histological analysis of PLDLA scaffolds 
implanted in rats
To evaluate the in vivo biocompatibility and influence of 
the PLDLA scaffolds on bone healing, cell-seeded PLDLA 
scaffolds (constructs) were implanted in bilateral critical-size 
calvarial defects in Wistar rats and assessed histologically at 
8 and 12 weeks after implantation. All rats recovered well 
during the post-surgical procedure, with no clinical signs 
of acute infection in the area of the defect and no systemic 
complications, which were only assessed macroscopically.
Figure 5 shows histological images of PLDLA constructs 
8 weeks after implantation. In the control group (empty 
defect), the center of the defect area was filled with thin fibrous 
Figure 2. Viability of osteoblastic-like cells cultured on PLDLA 
scaffolds for 2 h and 24 h . Cell viability was assessed by the MTT 
assay and expressed as the absorbance of the purple formazan 
product indicative of viable cells . The positive control consisted of 
cells grown in TCPS wells without any additions, while the negative 
control consisted of cells exposed to 10% phenol. The columns are 
the mean ± SD of five independent experiments. *p<0.01 compared 
to the control and PLDLA groups.
Figure 3.Proliferation of osteoblast-like cells grown on PLDLA 
scaffolds for 21 days. The points represent the mean ± SD of five 
independent experiments.
Figure 4. (A) Scanning electron micrograph of the surface of a PLDLA scaffold. (B) Osteoblastic-like cells cultured on a PLDLA scaffold 
for 24 h. (C) Beginning of cell colonization in non-specific areas of the scaffold surface after 7 days in culture. (D) Formation of net-like 
tissue covering the surface pores of a PLDLA scaffold after 14 days in culture.
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connective tissue while there was minimal bone formation 
at the borders of the defect (Figure 5A).
There was greater bone formation surround the margins 
of defect in the implants of the PLDLA constructs compared 
to the control group (Figure 5B), indicating that the 3D 
structure of the scaffolds was able to stimulate tissue ingrowth 
by providing mechanical assistance until the newly formed 
bone tissue assumed its biological functions. There was 
also an obvious belt of connective tissue fibers surrounding 
the space occupied by the material and the margins of the 
defect (Figure 5C).
Implantable biomaterials are recognized as foreign by the 
body and immediately after implantation, induce an initial host 
response to eliminate this foreign body. The magnitude and 
duration of the inflammatory process has a major influence 
on the stability and biocompatibility of the device 27.
Figure 5D shows that a severe inflammatory response 
involving the infiltration of leukocytes, macrophages and 
giant cells was observed with all PLDLA implants. These 
reactions occurred primarily in the center of the defects, 
around the particle-polymer interface within the scaffold. 
The inflammatory response observed in the implants was not 
considered to be indicative of a toxic effect of the PLDLA 
constructs but was most likely related to the rapid degradation 
of the PLDLA polymer at this stage, which can result in a high 
concentration of polymer fragments and local acidification 
of the implanted area 8,11,28,29.
The previous in vitro analysis of PLDLA degradation 
showed that material degradation starts after 8 weeks and is 
less pronounced after 16 weeks. It means that fewer polymer 
fragments and acidic degradation products are generated at 
the site of implant in the latter interval1,12. Besides, we have 
reported a similar PLDLA degradation rate and decrease in 
the inflammatory response along the time in the simulated 
internal fixation of PLDLA devices such as plates and screws 
in rabbit tibial implants30.
Figure 6 shows the histological appearance of PLDLA 
constructs after 12 weeks of implantation.
Panel A of this figure shows the presence of fibrous 
connective tissue in the control defect, although in two of 
four animals the control defect was also filled with a thin, 
uniform layer of newly formed bone (data not shown), 
indicating that the 5mm critical size defect used was not 
optimal for this study.
Calvarial critical size bone defects have been used in various 
studies to investigate the effectiveness of bone regenerative 
agents such as growth factors, biomaterials, cell or tissue 
implants, or any combination of these in repairing defective 
bone. However, the optimal critical size for bone calvarial 
defects within a given species remains controversial31,32.
In relation to the PLDLA scaffolds used in this work 
(Figure 6B), we observed active new bone formation in the 
central area of the implants that showed continuity with bone 
tissue growing inwards from the defect margins. In addition, 
a considerable amount of new thin bone trabeculae was 
observed surrounding the material implanted in the defect. 
However, in only one case the defect was completely filled 
with newly formed bone.
The inflammatory reaction within the implant decreased 
over time when compared with that seen after 8 weeks of 
implantation. The fibrous connective tissue became more 
disordered at the margins of control and implanted defects 
Figure 5. Histological alterations eight weeks after scaffold 
implantation. Light microscopy (HE) of the critical size calvarial 
defect at the control (empty defect) and scaffold-treated (PLDLA 
construct) sites. (A) The control site showed the presence of thin 
fibrous tissue (FT). (B) Panoramic image of the implanted PLDLA 
construct. (C) Fibrous tissue (FT) formed at the interface between 
new bone (NB) and the PLDLA scaffold implantat the defect margin. 
(D) Severe inflammatory reaction (IR) showing lymphocytes, 
macrophages and foreign-body giant cells (arrows) inside the 
implanted PLDLA scaffold.
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(Figure 6C) and in the central area of the implant. A persistent 
tissue response was observed inside and around the remaining 
polymer fragments in the central area of newly formed bone 
(Figure 6D), thus confirming that the severe inflammatory 
response seen after 8 weeks was caused essentially by factors 
related to polymer degradation.
Careful histological analysis showed that the areas of 
newly formed bone gradually joined up to close the defect. 
During this process, the rate of PLDLA scaffold degradation 
was similar to that of bone formation since no signs of impaired 
bone growth, such as necrosis and fibrous capsule formation 
around the implanted material, were observed. These results 
indicated a good interaction at the interface between newly 
bone formed and the implanted PLDLA construct 33.
Although the histological analysis has revealed that the 
PLDLA constructs were biocompatible with bone tissue and 
were not cytotoxic during tissue repair, we assumed that 
some factors related to the porogen-leaching method used to 
manufacture the scaffolds may have affected the interactions 
between the PLDLA constructs and native tissue, thereby 
preventing better PLDLA scaffold-cell interaction and bone 
formation. Such factors include the lack of control of pore 
interconnectivity and pore size within the scaffold and the 
difficulty in obtaining scaffolds ~1mm thick (a thickness 
close to that of native calvarial). These factors may have 
influenced the scaffold permeability and hindered fluid diffusion 
through the polymeric network. This in turn would affect 
polymer degradation and hinder the transport of nutrients to 
the implanted area and to cells pre-seeded on scaffolds34-36.
Within the limits of this study, the contribution and influence 
of transplanted osteoblast-like cells in bone replacement 
could not be assessed in terms of enhanced bone formation. 
However, histological results provided evidences on the 
benefits of using PLDLA scaffolds as synthetic temporary 
matrix in bone repair process, supporting a better growth 
and distribution of bone formation within the implanted area 
that was not seen in the control group. The latter generally 
showed only a uniform, thin bone layer covering the defect.
CONCLUSIONS
The results of this study have shown the potential 
usefulness of PLDLA copolymer as a scaffold for bone 
replacement procedures. The porogen-leached scaffolds 
were biocompatible with bone tissue and supported and 
stimulated osteoblast-like cell growth and migration, and 
still indicate the maintenance of cell morphology. The use 
of PLDLA cell-scaffold constructs in vivo showed that the 
material was mechanically stable, with a degradation rate 
similar to that of bone formation. The 3D structure of the 
constructs facilitated tissue growth into the implanted area 
and stimulated better distribution of the starting points of 
bone formation. More detailed studies of PLDLA polymer 
as a scaffold for bone regeneration are needed to confirm its 
usefulness for bone tissue engineering.
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Figure 6. Histological alterations 12 weeks after scaffold implantation. 
Light microscopy (HE) of the critical size calvarial defect at 
control (empty defect) and scaffold-treated (PLDLA construct) 
implants. (A) Control site filled with thin fibrous connective tissue. 
(B) Bone formation in the center of the implant. (C) Presence of 
active osteoblasts (OB) around newly formed bone at the margin 
of a defect implanted with a PLDLA scaffold. Note the presence of 
fibrous tissue (FT) at the interface between new bone (NB) and space 
of implanted PLDLA. (D) New bone (NB) in a defect implanted 
with a PLDLA scaffold. Note the inflammatory reaction (arrow) 
and active osteoblasts (OB) surrounding the remaining polymeric 
fragments areas.
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